Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress

Oncogene

Volumn 30, Issue 34, 2011, Pages 3716-3726

  Dong, L ^a   Jiang, C C ^a   Thorne, R F ^b   Croft, A ^a   Yang, F ^a   Liu, H ^a   De Bock, C E ^b   Hersey, P ^a   Zhang, X D ^a  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

endoplasmic reticulum stress; Ets 1; Mcl 1; Melanoma; XBP 1

Indexed keywords

PROTEIN IRE1; PROTEIN MCL 1; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR ETS 1; X BOX BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; MELANOMA CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOPLASMIC RETICULUM; HUMANS; MELANOMA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 80052074729     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.87     Document Type: Article

References (51)

1. Akgul C, Turner PC, White MR, Edwards SW. (2000). Functional analysis of the human MCL-1 gene. Cell Mol Life Sci 57: 684-691. (Pubitemid 30311437)
2. Bories JC, Willerford DM, Grevin D, Davidson L, Camus A, Martin P et al. (1995). Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377: 635-638.
3. Chen C, Edelstein LC, Gelinas C. (2000). The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20: 2687-2695. (Pubitemid 30183487)
4. Cory S, Adams JM. (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656. (Pubitemid 37328916)
5. Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Trope CG et al. (2001). Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome. Am J Surg Pathol 25: 1493-1500. (Pubitemid 33096963)
6. Dittmer J. (2003). The biology of the Ets1 proto-oncogene. Mol Cancer 2: 29.
7. Elbein AD. (1987). Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu Rev Biochem 56: 497-534. (Pubitemid 17105464)
8. Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R et al. (2001). Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 107: 351-362.
9. Fritsch RM, Schneider G, Saur D, Scheibel M, Schmid RM. (2007). Translational repression of MCL-1 couples stress-induced eIF2 alpha phosphorylation to mitochondrial apoptosis initiation. J Biol Chem 282: 22551-22562. (Pubitemid 47267367)
10. Gillespie S, Zhang XD, Hersey P. (2005). Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis. Mol Cancer Ther 4: 668-676. (Pubitemid 40601849)
11. Hahne JC, Okuducu AF, Sahin A, Fafeur V, Kiriakidis S, Wernert N. (2008). The transcription factor ETS-1: its role in tumour development and strategies for its inhibition. Mini Rev Med Chem 8: 1095-1105.
12. Harding HP, Calfon M, Urano F, Novoa I, Ron D. (2002). Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol 18: 575-599. (Pubitemid 35387362)
13. Hersey P, Zhuang L, Zhang XD. (2006). Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model. Int Rev Cytol 251: 131-158. (Pubitemid 44291415)
14. Hersey P, Zhang XD. (2008). Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma. Pigment Cell Melanoma Res 21: 358-367. (Pubitemid 351678087)
15. Iglesias-Serret D, Pique M, Gil J, Pons G, Lopez JM. (2003). Transcriptional and translational control of Mcl-1 during apoptosis. Arch Biochem Biophys 417: 141-152. (Pubitemid 36993789)
16. Isomoto H, Kobayashi S, Werneburg NW, Bronk SF, Guicciardi ME, Frank DA et al. (2005). Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocar-cinoma cells. Hepatology 42: 1329-1338. (Pubitemid 43260035)
17. Jiang CC, Wroblewski D, Yang F, Hersey P, Zhang XD. (2009a). Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax. Neoplasia 11: 945-955.
18. Jiang CC, Lucas K, Avery-Kiejda KA, Wade M, deBock CE, Thorne RF et al. (2008). Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res 68: 6708-6717.
19. Jiang CC, Yang F, Thorne RF, Zhu BK, Hersey P, Zhang XD. (2009b). Human melanoma cells under endoplasmic reticulum stress acquire resistance to microtubule-targeting drugs through XBP-1-mediated activation of Akt. Neoplasia 11: 436-447.
20. Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD et al. (2007). Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Cancer Res 67: 9750-9761. (Pubitemid 47621222)
21. Jiang CC, Mao ZG, Avery-Kiejda KA, Wade M, Hersey P, Zhang XD. (2009c). Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. Carcinogenesis 30: 197-204.
22. Jiang CC, Lai F, Tay KH, Croft A, Rizos H, Becker TM et al. (2010). Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of BimS. Cell Death Dis 1: e69; doi:10.1038/cddis.2010.48.
23. Jorcyk CL, Garrett LJ, Maroulakou IG, Watson DK, Green JE. (1997). Multiple regulatory regions control the expression of Ets-1 in the developing mouse: vascular expression conferred by intron I. Cell Mol Biol (Noisy-le-grand) 43: 211-225.
24. Li R, Pei H, Watson DK, Papas TS. (2000). EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 19: 745-753. (Pubitemid 30107705)
25. Liu H, Jiang CC, Lavis CJ, Croft A, Dong L, Tseng HY et al. (2009). 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2. Mol Cancer 8: 122.
26. Majeacuterus MA, Bibollet-Ruche F, Telliez JB, Wasylyk B, Bailleul B. (1992). Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter. Nucleic Acids Res 20: 2699-2703.
27. Mhaidat NM, Zhang XD, Jiang CC, Hersey P. (2007). Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin Cancer Res 13: 1308-1314. (Pubitemid 46424072)
28. Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y et al. (2005). Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin Cancer Res 11: 2111-2122. (Pubitemid 40490167)
29. Nguyen T, Zhang XD, Hersey P. (2001). Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Clin Cancer Res 7(3 Suppl): 966s-973s. (Pubitemid 33600952)
30. Piret JP, Minet E, Cosse JP, Ninane N, Debacq C, Raes M et al. (2005). Hypoxia-inducible factor-1-dependent overexpression of myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J Biol Chem 280: 9336-9344. (Pubitemid 40409627)
31. Poser I, Bosserhoff AK. (2004). Transcription factors involved in development and progression of malignant melanoma. Histol Histopathol 19: 173-188. (Pubitemid 38111262)
32. Rothhammer T, Hahne JC, Florin A, Poser I, Soncin F, Wernert N et al. (2004). The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61: 118-128. (Pubitemid 38121905)
33. Sagara Y, Inesi G. (1991). Inhibition of the sarcoplasmic reticulum Ca2+ transport ATPase by thapsigargin at subnanomolar concentrations. J Biol Chem 266: 13503-13506. (Pubitemid 21907377)
34. Sato Y, Teruyama K, Nakano T, Oda N, Abe M, Tanaka K et al. (2001). Role of transcription factors in angiogenesis: Ets-1 promotes angiogenesis as well as endothelial apoptosis. Ann NY Acad Sci 947: 117-123. (Pubitemid 34059907)
35. Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM et al. (2010). Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463: 103-107.
36. Schroder M, Kaufman RJ. (2005). The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789. (Pubitemid 40995523)
37. Soengas MS, Lowe SW. (2003). Apoptosis and melanoma chemore-sistance. Oncogene 22: 3138-3151.
38. Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV et al. (2002). Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 21: 8506-8509. (Pubitemid 36054891)
39. Teruyama K, Abe M, Nakano T, Iwasaka-Yagi C, Takahashi S, Yamada S et al. (2001). Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells. J Cell Physiol 188: 243-252. (Pubitemid 32622915)
40. Torlakovic EE, Bilalovic N, Nesland JM, Torlakovic G, Florenes VA. (2004). Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis. Mod Pathol 17: 1400-1406. (Pubitemid 39472996)
41. Wagner N, Michiels JF, Schedl A, Wagner KD. (2008). The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo. Oncogene 27: 3662-3672. (Pubitemid 351912975)
42. Wang YF, Jiang CC, Kiejda KA, Gillespie S, Zhang XD, Hersey P. (2007). Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1. Clin Cancer Res 13: 4934-4942. (Pubitemid 47294802)
43. Wang JM, Lai MZ, Yang-Yen HF. (2003). Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway. Mol Cell Biol 23: 1896-1909.
44. Warr MR, Shore GC. (2008). Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med8: 138-147. (Pubitemid 351516833)
45. Yang F, Tay KH, Dong L, Thorne RF, Jiang CC, Yang E et al. (2010). Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells. Cell Death Differ 17: 1354-1367.
46. Zhang K, Kaufman RJ. (2004). Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 279: 25935-25938. (Pubitemid 38798732)
47. Zhang Z, Kobayashi S, Borczuk AC, Leidner RS, Laframboise T, Levine AD et al. (2010). Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells. Carcinogenesis 31: 577-586.
48. Zhong Q, Gao W, Du F, Wang X. (2005). Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121: 1085-1095. (Pubitemid 40884398)
49. Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang XD, Thompson JF et al. (2007). Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Mod Pathol 20: 416-426. (Pubitemid 46482365)
50. Zhuang L, Scolyer RA, Lee CS, McCarthy SW, Cooper WA, Zhang XD et al. (2009). Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology 54: 462-470.
51. Zhuang L, Scolyer RA, Murali R, McCarthy SW, Zhang XD, Thompson JF et al. (2010). Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Mod Pathol 23: 45-53.